About the Cytotherapy Session
Cytotherapy represents a promising avenue in cancer research, leveraging the body's own cells to combat the disease. This innovative approach involves harnessing the power of immune cells, such as T cells, to target and destroy cancerous cells. One notable technique is CAR-T cell therapy, where T cells are genetically modified to express chimeric antigen receptors (CARs) that recognize specific proteins on cancer cells. Upon infusion back into the patient, these engineered T cells can effectively seek out and eliminate tumors.
Moreover, cytotherapy extends beyond CAR-T cells, encompassing various strategies like dendritic cell vaccines and natural killer (NK) cell therapy. These therapies hold immense potential for personalized cancer treatment, offering tailored solutions based on individual immune profiles. As research progresses, cytotherapy continues to evolve, bringing hope for more effective and targeted cancer therapies with potentially fewer side effects.
Topics Covered in Cytotherapy
CAR-T Engineering
TIL Therapy
NK Cell Therapy
TCR-Engineered T Cells
Cell Manufacturing
Cytokine Release Syndrome
Related Scientific Sessions at CIOC 2027
Why Attend the Cytotherapy Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cytotherapy work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cytotherapy research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cytotherapy track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cytotherapy Conference 2027 — FAQs
What is the Cytotherapy track at CIOC 2027?
The Cytotherapy track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cytotherapy. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cytotherapy sessions?
Cancer researchers and clinicians, educators and students with an interest in Cytotherapy are all welcome — whether presenting or attending.
Can I present my research in the Cytotherapy track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cytotherapy sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cytotherapy track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.